Barry Labinger is the founder of Checkmate Pharmaceuticals. Checkmate Pharmaceuticals has raised $85M in total funding. Latest round: Series C.
Barry Labinger is a biotech executive who served as President and CEO of Checkmate Pharmaceuticals, a clinical-stage biopharmaceutical company focused on cancer immunotherapy. He oversaw an $85 million Series C financing and a subsequent $75 million IPO for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library